NCT05080166View on ClinicalTrials.gov

UPLYFT For Lymphoma Survivors

NARecruitingINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

February 8, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

March 31, 2026

Conditions
LymphomaSurvivorship
Interventions
OTHER

Interview with Clinicians

One time, qualitative interview of clinicians for feedback on UPLYFT intervention

OTHER

Field Test of UPLYFT with Lymphoma Survivors

6 session of UPLYFT intervention with Lymphoma Survivors for feedback

BEHAVIORAL

Pilot of UPLYFT with Lymphoma Survivors

6 session of UPLYFT intervention with Lymphoma Survivors

Trial Locations (1)

02215

RECRUITING

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

American Society of Hematology

OTHER

lead

Dana-Farber Cancer Institute

OTHER